244 related articles for article (PubMed ID: 2823896)
1. Proteolytic degradation of extracellular matrix in tumor invasion.
Tryggvason K; Höyhtyä M; Salo T
Biochim Biophys Acta; 1987 Nov; 907(3):191-217. PubMed ID: 2823896
[No Abstract] [Full Text] [Related]
2. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
Blasi F; Stoppelli MP
Biochim Biophys Acta; 1999 Jan; 1423(1):R35-44. PubMed ID: 9989212
[No Abstract] [Full Text] [Related]
3. Biology and biochemistry of proteinases in tumor invasion.
Mignatti P; Rifkin DB
Physiol Rev; 1993 Jan; 73(1):161-95. PubMed ID: 8419965
[No Abstract] [Full Text] [Related]
4. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
Mueller BM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
Reich R; Thompson EW; Iwamoto Y; Martin GR; Deason JR; Fuller GC; Miskin R
Cancer Res; 1988 Jun; 48(12):3307-12. PubMed ID: 2836052
[TBL] [Abstract][Full Text] [Related]
6. Tumor and host molecules important in the organ preference of metastasis.
Nicolson GL
Semin Cancer Biol; 1991 Jun; 2(3):143-54. PubMed ID: 1912524
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
Persky B; Ostrowski LE; Pagast P; Ahsan A; Schultz RM
Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic enzymes in cancer invasion and metastasis.
Goldfarb RH; Liotta LA
Semin Thromb Hemost; 1986 Oct; 12(4):294-307. PubMed ID: 3024322
[No Abstract] [Full Text] [Related]
9. Role for different cell proteinases in cancer invasion and cytolysis.
Zucker S; Beck G; DiStefano JF; Lysik RM
Br J Cancer; 1985 Aug; 52(2):223-32. PubMed ID: 2992566
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix injury during lung inflammation.
Campbell EJ; Senior RM; Welgus HG
Chest; 1987 Jul; 92(1):161-7. PubMed ID: 3036424
[No Abstract] [Full Text] [Related]
11. Extracellular matrix-degrading proteinases in the nervous system.
Romanic AM; Madri JA
Brain Pathol; 1994 Apr; 4(2):145-56. PubMed ID: 8061860
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic enzymes in proliferation and neoplastic metastases formation.
Gołaszewski Z; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():48-59. PubMed ID: 9337523
[TBL] [Abstract][Full Text] [Related]
13. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix metalloproteinases in tumor invasion and metastasis.
Goldberg GI; Eisen AZ
Cancer Treat Res; 1991; 53():421-40. PubMed ID: 1672089
[No Abstract] [Full Text] [Related]
15. Matrix-degrading proteases in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Breast Cancer Res Treat; 1994; 31(2-3):167-73. PubMed ID: 7881096
[TBL] [Abstract][Full Text] [Related]
16. Proteases, angiogenesis, and invasion.
Rifkin DB; Moscatelli D; Gross J; Jaffe E
Symp Fundam Cancer Res; 1983; 36():187-200. PubMed ID: 6206538
[No Abstract] [Full Text] [Related]
17. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
[TBL] [Abstract][Full Text] [Related]
18. Tumor invasion and the extracellular matrix.
Liotta LA; Rao CN; Barsky SH
Lab Invest; 1983 Dec; 49(6):636-49. PubMed ID: 6317982
[No Abstract] [Full Text] [Related]
19. Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation.
Opdenakker G; Paemen L; Norga K; Masure S
Int J Cancer; 1997 Mar; 70(5):628-30. PubMed ID: 9052766
[No Abstract] [Full Text] [Related]
20. The biochemistry of cancer dissemination.
Price JT; Bonovich MT; Kohn EC
Crit Rev Biochem Mol Biol; 1997; 32(3):175-253. PubMed ID: 9239493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
